GlassScriptPhysician profile
Harold E Parsons
NPI 1598916942
$1,170.87
in general payments reported to CMS, 2019-2025
18 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $337 · 2022: $175 · 2023: $173 · 2024: $215 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $207.33 | 2021-2022 | |
| Djo, LLC | $156.08 | 2021-2025 | Cmf |
| Stryker Corporation | $154.25 | 2022-2025 | Variax, T2 |
| Vertex Pharmaceuticals Incorporated | $124.97 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $82.08 | 2022-2025 | Zilretta, Iovera, Exparel |
| Horizon Therapeutics Plc | $69.29 | 2021-2022 | |
| Radius Health, INC. | $55.61 | 2021-2024 | Tymlos |
| Heron Therapeutics, INC. | $55.40 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $42.71 | 2021-2023 | Monovisc, Orthovisc |
| Astrazeneca Pharmaceuticals LP | $38.80 | 2023-2025 | Wainua |
| Ferring Pharmaceuticals INC. | $38.36 | 2021-2023 | Euflexxa |
| Innovation Technologies INC | $31.86 | 2025 | Irrisept |
| Bioventus LLC | $29.94 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $19.39 | 2024 | Vistaseal |
| Cordis US Corp. | $18.62 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $16.58 | 2023 | Xiaflex |
| Endo USA, INC. | $15.28 | 2025 | Xiaflex |
| Midsouth Orthopedics INC. | $14.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Parsons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.